Evidence that certain 8-aminoquinolines are potentially effective drugs against Chagas disease

Annals of Tropical Medicine and Parasitology

Volumn 91, Issue 2, 1997, Pages 147-152

  Kinnamon, K E ^a,c   Poon, B T ^a   Hanson, W L ^b   Waits, V B ^b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 AMINOQUINOLINE DERIVATIVE; NIFURTIMOX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; MOUSE; NONHUMAN; PARASITEMIA; TRYPANOSOMA CRUZI;

ANIMALIA; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0030951555     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1080/00034983.1997.11813124     Document Type: Article

References (14)

1. BRENER, Z. (1979). Present status of chemotherapy and chemoprophylaxis of human trypanosomiasis in the western hemisphere. Pharmacology and Therapeutics, 7, 71-90.
2. CLARK, A. M., BAKER, J. K. & MCCHESNEY, J. D. (1984). Excretion, distribution, and metabolism of primaquine in rats. Journal of Pharmaceutical Sciences, 73, 502-506.
3. GOBLE, F. C. (1949). Chemotherapeutic activity of certain 8-aminoquinolines, particularly pentaquine in experimental Chagas' disease. Journal of Parasitology, 35, 375-378.
4. GOBLE, F. C. (1952). Activity of certain 6-methoxy-8-amino quinolines against Trypanosoma cruzi. Antibiotics and Chemotherapy, 2, 265-270.
5. GUTTERIDGE, W. E. (1985). Existing chemotherapy and its limitations. British Medical Bulletin, 41, 162-168.
6. KIERSZENBAUM, F. (1984). The chemotherapy of Trypanosoma cruzi infections (Chagas' Disease). In Parasitic Diseases, Vol. 2, The Chemotherapy, ed. Mansfield, J. M. pp. 133-163. New York: Marcel Deckker.
7. KINNAMON, K. E., STECK, E. A., HANSON, W. L. & CHAPMAN JR, W. L. (1977). In search of anti-Trypanosoma cruzi drugs: new leads from a mouse model. Medicinal Chemistry, 20, 741-744.
8. KINNAMON, K. E., POON, B. T., HANSON, W. L. & WAITS, V. B. (1996). Primaquine analogues that are potent anti-Trypanosoma cruzi agents in a mouse model. Annals of Tropical Medicine and Parasitology, 90, 467-474.
9. MCCABE, R. E. (1988). Primaquine is lethal for intracellular but not extracellular Trypanosoma cruzi. Journal of Parasitology, 74, 748-753.
10. MIHALY, G. W., WARD, S. A., EDWARDS, G., ORME, M. L'E. & BRECKENRIDGE, A. M. (1984). Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite. British Journal of Clinical Pharmacology, 17, 441-446.
11. PIZZI, T. (1951). Effect of primaquine on experimental Trypanosoma cruzi infection. Proceedings of the Society for Experimental Biology and Medicine, 78, 643-644.
12. STECK, E. A. (1972). Chemotherapy of Chagas' disease. In The Chemotherapy of Protozoan Diseases, Vol. 2, pp. 9.1-9.56 (Walter Reed Army Institute of Research Publication 0-462-578). Washington, DC: United States Printing Office.
13. THOMPSON, P. E. & BAYLES, A. (1970). Effects of triamino-quinazolines against Trypanosoma cruzi in mice. Journal of Parasitology, 56, 616-617.
14. WORLD HEALTH ORGANIZATION (1995). Tropical Disease Research, 12th Programme Report of the UNDP/ World Rank/WHO, Special Programme for Research and Training in Tropical Disease. Geneva: WHO.